China’s HD Biosciences Completes Series A Financing; Led By Lilly, Pfizer And Morningside

SHANGHAI - HD Biosciences has completed its first round of external financing, led by Morningside Group and Lilly Asian Ventures and syndicated with Pfizer Venture Investments, the company announced Aug. 7

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip